Amer Zeidan/LinkedIn
Aug 19, 2026, 07:02
Amer Zeidan: Managing Anemia in Lower-Risk MDS
Amer Zeidan, Chief, Division of Hematologic Malignancies; Professor of Medicine at Yale University, shared a post on LinkedIn:
“Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy.”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 16:03Professor Csongor Kiss Receives the Kálmán Laki Prize – Hungarian Society of Thrombosis and Haemostasis
-
Oct 6, 2026, 15:52Mark Kheifets: A Massive Stent Thrombosis Requiring Aspiration Thrombectomy
-
Oct 6, 2026, 15:40Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity
-
Oct 6, 2026, 15:36Nominations Open for ISTH Outstanding Mentor Awards – ISTH
-
Oct 6, 2026, 15:17Walaa Obaid: How Warfarin Went From Poison To Medicine
-
Oct 6, 2026, 15:16Nathan Hutchinson-Jones: Pharmacist-Led Care Optimises Cancer-Associated Thrombosis
-
Oct 6, 2026, 14:46Counting Down to WTD With a Focus on Thrombosis in Pregnancy
-
Oct 6, 2026, 14:29Jorge Enrique: Navigating Anticoagulation in Pregnancy With a Prosthetic Heart Valve
-
Oct 6, 2026, 14:20Hassan Abdelhak: Understanding How LVADs Support the Failing Heart